N. Sakellaris

Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.

A. Manolis, A. Kranidis, H. Melita, 2005, Current drug targets. Cardiovascular & haematological disorders.

Indications for Renal Artery Stenting

A. Manolis, H. Anninos, Nikolaos Sakellaris, 2009 .

Secondary Percutaneous Revascularization for Severe Unprotected Left Main Disease After Surgical Turndown

K. Triantafyllou, K. Kappos, Dimitrios Stalikas, 2017 .

Thromboaspiration of Heavy Thrombotic Load Salvages Myocardium and Prevents the No-Reflow Phenomenon in Acute Myocardial Infarction

A. Manolis, Nikolaos Sakellaris, Spyridon Koulouris, 2010 .

Adverse Cardiovascular Effects and Drug Interactions with Herbs

I. Chaveles, Ioannis Pyrros, Nikolaos Sakellaris, 2016 .

Novel Therapies for Resistant Hypertension

M. Misailidou, Xenia Stathopoulou, N. Sakellaris, 2010 .

Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring.

A. Manolis, S. Metaxa, Ioannis Pyrros, 2018, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Salt Controversy Stirred by “PURE” but Settled by “NUTRICODE”

A. Manolis, Ioannis Pyrros, Nikolaos Sakellaris, 2014 .

Bifocal Right Ventricular Pacing: Alternative to Biventricular Pacing for Cardiac Resynchronization Therapy?

A. Manolis, S. Metaxa, N. Sakellaris, 2014 .